Литература. 
Табакокурение и болезни органов дыхания

1. Adler L. Primary malignant growth of the lungs and bronchi. New York, Longmans Green, 1912.

2. Thatcher TH., Maggirwar SB., Baglole., Lakatos HF., Gasiewicz TA., Phipps RP., Sime PJ: Aryl hydrocarbon receptor deficient mice develop heitened inflammatory rwsponses in cigarette smoke and endotoxin associated with rapid loss of the nuclear factor kappaB component RelB. Am J Parhol 2007;170: 855 864.

3. Yang SR., Wright J., Bauter M., Seweryniak K., Kode A., Rahman I.: Sirtuin regulates cigarette smoke induced pro inflamotory mediator release via RelA/p65 NF kappaB in macrophages in vitro and in rat lungs in vivo: implications for chronic inflammation and aging. Am J Physiol Lung Cell Mol Physiol 2007; 292: L567 L576.

4. Rahman I., Adcock IM. Oxidative stress and redox regulation of lung inflammation in COPD. Eur Respir J 2006; 28: 219 242 .

5. Yoshida T., Tuder RM. Pathobiology of cigarette smoke induced COPD. Physiolog. Rev 2007;87:1047 1082.

6. Tsuji T., Aoshiba K., Nagai A. Alveolar cell senescence in patients with pulmonary emphysema. Am J Respir Crit Care Med 2006; 174: 886 893/.

7. Sherr CJ., Roberts JM. Inhibitors of mammalian G1 cyclin dependent kinases. Genes Dev 1995; 9:1149 1163.

8. Macip S., Igarashi M., Fang L., Chen A., Pan ZQ., Lee W., Aaronson SA. Inhibition of p21 mediated ROS accumulation can rescue p21 induced senescence. EMBO J 2002;21: 2180 88.

9. Marcotte R., Wang E. Replicative senescence revisited. J Gerontolog. A Biol Sci Med Sci 2002;57: B257 69).

10. Yao H., Yang SR., Edirisinghe I., Rajendrasozhan S., Caito S., Adenuga D., Reilly MA., Rahman I. Distribution of p21 attenuates lung inflammation induced by cigarette smoke, LPS and fMLP in mice. Am J Respir Cell Mol Biol 2008;39, pp. 7 18.

11. Siedlinski M., Postma DS., van Diemen CC., Blokstra A., Smit H.A., Boezen HM. Lung function loss, smoking, vitamin C intake, and polymorphisms of the glutamate cysteine ligase genes. Am J Respir Critical Care Mad 2008; 178 pp. 13 19.

12. Nakamura S., Kugiyama K., Sugiyama S., Miayamoto S., Koide S., Fukushima H., Honda O., Yoshimura M., Ogawa H. Polymorphism in the 5? flanking region of human glutamate cysteine ligase modifier subunit gene is associated with myocardial infarction. Circulation 2002;105: 2968 2973.

13. Gysin R., Kraftsik R., Sandell J., Bovet P., Chappius C., Conus P., Deppen P., Preisig M., Ruiz M., Steullet P. Impaired glutathione synthesis in schizophrenia. Nat Acad Sci USA 2007; 104: 16 621 16 626.

14. Tager IB., Speizer FE. Risk estimates for chronic bronchitis in smokes: a study of male female differences. Am Rev Respir 1976; 116:619 625.

15. Eriksson S. Pulmonary emphysema and alpha 1 antitrypsin deficiency. Acta Med Scand 1964; 175:197.

16. Celedon JC., Speizer FE., Drazen JM., Weis ST., Campbell EJ., Carey VJ., Reilly JJ., Ginns L., Silverman EK. Bronchodilator responsiveness and serum total IgE levels in families of probands with severe early onset COPD. Eur Respir J 1999;14: 1009 14.

17. Chan Yeung M., Lam S., Koener S. Clinical features a natural history of occupational asthma due to western red cedar. Am J Med 1982; 72:411 415.

18. Doll R., Peto R., Boreham J., Sutherland I. Mortality in relation to smoking: 50 years observations on male doctors. BMJ 2004; 328: 1519.

19. Bassky SH., Roth MD., Kleerup EI., Simmons M., Tashkin DP. Histopathologic and molecular alterations in bronchial epithelium in habitual smokers of marijuana, cocaine and tobacco. J Natl Cancer Invest 1988; 90: 1198 1205.

20. Denissenko MF., Pao A., Tang M., Pfeifer GP. Preferential formation of benz[a]pyrene adducts of lung cancer mutational hotspots in p53. Science 1996; 274: 430 2.